Virtus Investment Advisers’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-36,338
Closed -$778K 512
2024
Q4
$778K Sell
36,338
-3,107
-8% -$75.6K 0.61% 37
2024
Q3
$1.23M Sell
39,445
-15,700
-28% -$391K 0.97% 19
2024
Q2
$856K Buy
55,145
+17,000
+45% +$205K 0.72% 31
2024
Q1
$404K Hold
38,145
0.29% 103
2023
Q4
$458K Buy
+38,145
New +$313K 0.34% 95

Other funds holding CDNA

Virtus Investment Advisers's CDNA Position: Q1 2025 in Review

Virtus Investment Advisers sold out of CareDx (CDNA) in Q1 2025, closing a stake of 36,338 shares — an estimated $778K sold.

Virtus Investment Advisers first reported a position in CDNA in Q4 2023 and held it in 5 quarters. The position peaked at $1.23M in Q3 2024. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.

  • Virtus Investment Advisers reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 36,338 CareDx shares in Q1 2025, an estimated $778K.
  • Virtus Investment Advisers first reported a position in CareDx in Q4 2023 and held it in 5 quarters.
  • Virtus Investment Advisers's CareDx position peaked at $1.23M in Q3 2024.
  • 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.